✳flâneur — a map of the web's best reading

The precipice of a biotech renaissance – the confluence of AI and SynBio

longevity.technology · 1,839 words · saved by 1 readers

Earlier this year, we reported on Integrated Biosciences, a biotech combining synthetic biology and machine learning to target aging, and its collaboration with researchers at the University of California Santa Barbara. They announced a drug discovery platform that enables precise control of the integrated stress response (ISR), a biological pathway that is activated by cells in response to a wide variety of pathological and aging-associated conditions. This platform, which was featured on the cover of Cell Systems, triggers the ISR virtually using light and reveals how the accumulation of stress over time shifts a cell’s reaction from adaptation to apoptosis (programmed cell death) [1]. Longevity.Technology: Intrigued by the role of machine learning in deciphering complex cellular stress responses, we sat down with Max Wilson, PhD, the cofounder of Integrated Biosciences, to find out more about how this knowledge can be applied to develop innovative therapeutics and the role synthetic

The precipice of a biotech renaissance – the confluence of AI and SynBio Skip to content AI/Tech Biotech Features Sep 29, 2023 Standing at the precipice of a biotech renaissance – the confluence of AI and SynBio Eleanor Garth Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision. Please get in touch if you are interested: Email ... or meeting booking link The coming together of two of the most transformative technologies of our age will shine a light on our understanding and manipulation of biological systems. Earlier th

Explore this link on the map →

related reading